AstraZeneca and drugmakers release promising cancer data
Attendees walk through the lobby of the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg…
Bristol-Myers Squibb Co.
This promising cancer treatment could represent a $25 billion market opportunity
Skynesher | E+ | fake images Big Pharma is betting billions on a promising class of cancer treatments that some…
Stocks set to move as this corner of the cancer therapy market heats up
Much attention has been paid lately to a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy…
Bristol Myers Squibb (BMY) earnings in the first quarter of 2024
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on December 27, 2023. Adam Glanzman…
J&J, Bristol Myers Squibb Lose Challenges in Medicare Drug Price Negotiations
Jonathan Raá | Nurfoto | fake images A federal judge in New Jersey on Monday rejected Johnson and Johnson'sand Bristol-Myers…
Biotech stocks are ready to break out. They just need one more thing
As debate continues over when the Federal Reserve might begin cutting interest rates, biotech industry analysts argue that the case…
J&J cell therapy gains advantage over Bristol Myers rival
Jonathan Raá | Nurfoto | fake images Do you think a friend or colleague should receive this newsletter? Share this…
Medicare drug price negotiations: Judge rejects AstraZeneca challenge
Activists protest prescription drug pricing outside the US Department of Health and Human Services building in Washington, DC, on October…
Medicare Drug Price Negotiations: Judge Dismisses PhRMA Lawsuit
Activists protest prescription drug pricing in front of the U.S. Department of Health and Human Services (HHS) building on October…
CEOs of Merck, J&J and Bristol Myers Squibb face Senate hearing on drug prices
Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey about issuing subpoenas for drug company CEOs…